Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges in neoantigen-directed therapeutics
Lien Lybaert, Steve Lefever, Bruno Fant, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 15-40
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Lu Diao, Mi Liu
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 63
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction
Li Tong, Yupeng Li, Xiaoyi Zhu, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 50-69
Closed Access | Times Cited: 24
Advancing nanotechnology for neoantigen-based cancer theranostics
Jianhua Zou, Yu Zhang, Yuanbo Pan, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 7, pp. 3224-3252
Open Access | Times Cited: 14
Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis
Haoran Wang, Jian-Kang Mu, Yexing Chen, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 12
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 10
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
Eleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 10
A microfluidics-enabled automated workflow of sample preparation for MS-based immunopeptidomics
Xiaokang Li, Hui Song Pak, Florian Huber, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 6, pp. 100479-100479
Open Access | Times Cited: 17
Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy
Peng Bao, Hui‐Yun Gu, Jing‐Jie Ye, et al.
Advanced Science (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 17
Neoantigen-directed therapeutics in the clinic: where are we?
Lien Lybaert, Kris Thielemans, Steven A. Feldman, et al.
Trends in cancer (2023) Vol. 9, Iss. 6, pp. 503-519
Open Access | Times Cited: 16
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 1121-1129
Closed Access | Times Cited: 7
High-quality peptide evidence for annotating non-canonical open reading frames as human proteins
Eric W. Deutsch, Leron W. Kok, Jonathan M. Mudge, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 6
In Situ Self‐Aggregation of Spirulina Skeleton Fibers Enhances the Efficacy of Anti‐Tumor Thermal Immunotherapy
Yong‐Dan Qi, Ze‐Nan Zhuang, Simin Zeng, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 19
Closed Access | Times Cited: 5
Tumor neoantigens: Novel strategies for application of cancer immunotherapy
Hanyang Guan, Yue Wu, Lu Li, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 4, pp. 437-448
Open Access | Times Cited: 15
Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy
Wenshe Sun, Shaowei Xie, Shi Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3919-3942
Open Access | Times Cited: 4
Harnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives
Zhenxin Bai, Xuanyu Wang, Tianming Liang, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 4
Immunopeptidomics mapping of Listeria monocytogenes T cell epitopes in mice
Adillah Gul, Lecia L. Pewe, Patrick Willems, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 9, pp. 100829-100829
Open Access | Times Cited: 4
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
Wenbo Ning, Yan Sheng, Yingquan Song, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity
Shuting Wu, Rong Xiang, Yiwei Zhong, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Effective design of therapeutic nanovaccines based on tumor neoantigens
Weilin Wang, Yujia Zhai, Xiaoye Yang, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 17-35
Closed Access
Tailoring Nanovectors for Optimal Neoantigen Vaccine Efficacy
Youshi Zheng, Binghe Wang, Zhixiong Cai, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Resistance to Immunotherapy in Non-small Cell Lung Cancer: Unraveling Causes, Developing Effective Strategies, and Exploring Potential Breakthroughs
Shuang Dong, Xiaoyu Li, Qing Huang, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101215-101215
Closed Access
Integration of proteomics profiling data to facilitate discovery of cancer neoantigens: a survey
S. Luo, Hui Peng, Ying Shi, et al.
Briefings in Bioinformatics (2025) Vol. 26, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top